Ultragenyx Pharmaceutical | RARE - صافي الدخل





صافي الدخل تغيير تاريخ
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Kyowa Hakko Kirin JPY 18.58B 6.55B 2026-06
MacroGenics USD -36.77M 22.62M 2026-03
Moderna USD -1.34B 517M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06